TREATMENT OF KNEE OSTEOARTHRITIS WITH SM04690 IMPROVED WOMAC A1 'PAIN ON WALKING' RESULTS FROM A 52 WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR

被引：5
|
作者：
Kennedy, S. [1 ]
Ghandehari, H. [1 ]
Swearingen, C. [1 ]
Tambiah, J. [1 ]
Hochberg, M. [2 ]
机构：
[1] Samumed LLC, San Diego, CA USA
[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5547
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0061
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [1] Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 "Pain on Walking" - Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor
    Tambiah, Jeyanesh
    Kennedy, Sarah
    Ghandehari, Heli
    Swearingen, Christopher
    Hochberg, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] Results from a 52 Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for the Treatment of Knee Osteoarthritis
    Yazici, Yusuf
    McAlindon, Timothy E.
    Gibofsky, Allan
    Lane, Nancy E.
    Clauw, Daniel J.
    Armas, Eddie
    Skrepnik, Nebojsa
    Swearingen, Christopher J.
    DiFrancesco, Anita
    Tambiah, Jeymi
    Hochberg, Marc
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Clauw, D. J.
    Jones, M. H.
    Bergfeld, J.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S293 - S294
  • [4] RESULTS FROM A 52 WEEK RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, WNT PATHWAY INHIBITOR (SM04690) FOR KNEE OSTEOARTHRITIS TREATMENT
    Yazici, Y.
    McAlindon, T.
    Gibofsky, A.
    Lane, N.
    Clauw, D.
    Swearingen, C.
    DiFrancesco, A.
    Tambiah, J.
    Hochberg, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1146 - 1147
  • [5] RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDYOFA NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    McAlindon, T.
    Gibofsky, A.
    Lane, N.
    Clauw, D.
    Grifman, M.
    Swearingen, C.
    DiFrancesco, A.
    Tambiah, J.
    Hochberg, M.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S137 - S137
  • [6] Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
    Swearingen, Christopher J.
    Majumdar, Sharmila
    Simsek, Ismail
    DiFrancesco, Anita
    Tambiah, Jeymi
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] RADIOGRAPHIC OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: WEEK 26 INTERIM ANALYSIS
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 121 - 121
  • [8] CLINICAL OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: WEEK 26 INTERIM ANALYSIS
    Yazici, Y.
    Gibofsky, A.
    Lane, N. E.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    McAlindon, T. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 985 - 986
  • [9] OMERACT-OARSI 'STRICT RESPONDERS' ANALYSIS FROM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Y.
    Tambiah, J.
    Swearingen, C. J.
    DiFrancesco, A.
    Strand, V.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S187 - S187
  • [10] SAFETY, CLINICAL AND IMAGING OUTCOMES OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: EXPLORATORY ANALYSIS OF RESULTS FROM A 24 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY
    Yazici, Y.
    McAlindon, T. E.
    Fleischmann, R. M.
    Gibofsky, A.
    Lane, N. E.
    Kivitz, A. J.
    Majumdar, S.
    Strand, V.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J.
    Hood, J.
    Hochberg, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 826 - 826
12345